Trials / Recruiting
RecruitingNCT06544629
Imjudo & Imfinzi PMS
Imjudo & Imfinzi Post-Marketing Surveillance
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 246 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Based on the re-review of new drugs article, Korean pharmaceutical act, the objectives of this study are to assess safety and effectiveness of the study drugs(Imjudo \& Imfinzi) in a real world setting in patients who treated according to the approved indications in Korea.
Detailed description
Primary Objective: To assess safety of the study drugs for patients treated with the study drugs under the approved indication in Korea Secondary Objective: To assess effectiveness of the study drugs for patients treated with the study drugs under the approved indication in Korea Exploratory Objective: To assess effectiveness of the study drugs for patients treated with the study drugs under the approved indication in Korea
Conditions
Timeline
- Start date
- 2025-04-14
- Primary completion
- 2029-02-28
- Completion
- 2029-02-28
- First posted
- 2024-08-09
- Last updated
- 2025-11-21
Locations
6 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06544629. Inclusion in this directory is not an endorsement.